National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 253 cases where Age is under-19 and Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Patient Did Not Die and Hospitalized and Vaccination Date from '2021-07-01' to '2021-07-31'

Government Disclaimer on use of this data



Case Details

This is page 6 out of 26

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next


VAERS ID: 1493763 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: Montana  
Vaccinated:2021-07-15
Onset:2021-07-17
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-07-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0177 / 2 - / IM

Administered by: Public       Purchased by: ?
Symptoms: C-reactive protein increased, Cardiac imaging procedure abnormal, Chest pain, Echocardiogram abnormal, Ejection fraction decreased, Fatigue, Immediate post-injection reaction, Immunoglobulin therapy, Left ventricular dysfunction, Myocarditis, Palpitations, Pericardial effusion, Right ventricular dysfunction, Right ventricular ejection fraction decreased, Troponin increased
SMQs:, Cardiac failure (narrow), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Pulmonary hypertension (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Melatonin
Current Illness: None
Preexisting Conditions: Autism Spectrum Disorder
Allergies: Amoxicillin
Diagnostic Lab Data: 7/17 Troponin 20,987 at 1450 and CRP 79.4. 7/17 Troponin 28,338 at 2336. 7/18 Troponin 23376, CRP 53. 7/19 Troponin 19,463, CRP 29. 7/20 Troponin 4,658, CRP 16.6. 7/21 Troponin 2,076, CRP 9.3. 7/17 Echo - LVEF 40-50%, with LV+RV mildly depressed systolic function + diastolic function. 7/19 Echo- LVEF 50%, low-normal function, slightly improved. 7/19 Cardiac MRI - Mildly decreased global LV systolic function (EF 47%), decreased RV systolic function (EF 37%), small pericardial effusion. 7/21 Echo normal.
CDC Split Type:

Write-up: Chest pain and palpitations, fatigue immediately post vaccine and chest pain starting 43 hours later. Admitted at 48 hours with troponin 20,000 and decreased biventricular function on echo (RVEF 37%) consistent with myocarditis. Symptomatic improvement post IVIG treatment. Hospital stay 4 days without arrhythmia or other events. Treated with IVIG alone.


VAERS ID: 1494097 (history)  
Form: Version 2.0  
Age: 12.0  
Sex: Male  
Location: North Carolina  
Vaccinated:2021-07-14
Onset:2021-07-16
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-07-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0180 / 2 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Echocardiogram normal, Electrocardiogram normal, Fatigue, Lipids normal, Metabolic function test normal, Pyrexia, Tachycardia, Tremor, Troponin normal
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Parkinson-like events (broad), Noninfectious encephalopathy/delirium (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Troponin was normal on 7/18 and 7/19. Normal comprehensive metabolic panel, normal lipid panel, normal EKG and echocardiogram., all done on 7/19.
CDC Split Type:

Write-up: Developed fever, fatigue, shaking, and tachycardia. Required admission to the hospital for observation due to persistent tachycardia and concern of myopericarditis. He did not develop myopericarditis or end organ dysfunction of (Privacy). He was discharge in approximately 48 hours and is continuing to improve.


VAERS ID: 1494141 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-07-18
Onset:2021-07-19
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-07-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EY0584 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Blood creatine phosphokinase increased, Chest pain, N-terminal prohormone brain natriuretic peptide increased, Pain, Troponin
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Troponin of 1.75, proBNP 333, CK 1010 (7/22/2021)
CDC Split Type:

Write-up: Chest pain (retrosternal with left side radiation, then becoming more generalized) 1 day following vaccine administration


VAERS ID: 1498001 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: New Hampshire  
Vaccinated:2021-07-15
Onset:2021-07-17
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-07-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Adenovirus test, Anion gap normal, Antibody test, Anticoagulant therapy, Band neutrophil percentage increased, Basophil count decreased, Basophil percentage decreased, Blood calcium normal, Blood chloride normal, Blood creatinine normal, Blood electrolytes normal, Blood glucose normal, Blood lactate dehydrogenase increased, Blood magnesium increased, Blood phosphorus normal, Blood potassium increased, Blood sodium normal, Blood urea normal, Brain natriuretic peptide normal, C-reactive protein increased, C-reactive protein normal, Carbon dioxide normal, Cardiac telemetry normal, Chest X-ray normal, Chest pain, Cytomegalovirus test, Cytomegalovirus test negative, Dyspnoea, Echocardiogram abnormal, Electrocardiogram ST segment elevation, Electrocardiogram repolarisation abnormality, Enterovirus test, Eosinophil count decreased, Eosinophil percentage decreased, Epstein-Barr virus antibody, Epstein-Barr virus test negative, Fibrin D dimer normal, Full blood count normal, Haematocrit normal, Haemoglobin normal, Headache, Herpes simplex test, Hypokinesia, Immature granulocyte count increased, Immature granulocyte percentage increased, Immunoglobulin therapy, Influenza virus test negative, Laboratory test, Lymphocyte count decreased, Lymphocyte percentage decreased, Magnetic resonance imaging heart, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume normal, Microbiology test, Monocyte count, Monocyte percentage, Mycoplasma test, Myocarditis, Neutrophil count, Parvovirus B19 test, Platelet count normal, Pyrexia, Red blood cell count normal, Red blood cell nucleated morphology, Red blood cell sedimentation rate normal, Red cell distribution width normal, Respiratory syncytial virus test negative, Respiratory viral panel, SARS-CoV-2 antibody test positive, SARS-CoV-2 test negative, Serum ferritin normal, Stool analysis, Systolic dysfunction, Tachypnoea, Transaminases increased, Troponin T increased, Troponin increased, Urine analysis, Viral test, Wall motion score index normal, White blood cell count normal
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (broad), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Haematopoietic leukopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (narrow), Conduction defects (narrow), Parkinson-like events (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypotonic-hyporesponsive episode (broad), Chronic kidney disease (broad), Myelodysplastic syndrome (broad), Tumour lysis syndrome (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Infective pneumonia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: h/o asthma
Allergies: Penicillin
Diagnostic Lab Data: See above
CDC Split Type:

Write-up: **Please note - we do not have access to the immunization registry and cannot provide lot numbers or exact dates** Admission Date/Time: 07/18/2021 18:23:00 Discharge Date/Time: 07/21/2021 12:53:15 Chief Complaint COVID vaccine myocarditis Patient Narrative ILLNESS SEVERITY: The patient is returning to baseline, requires assessment. PATIENT SUMMARY: Reason for Hospitalization: Chest pain Admission HPI: a 17 year old young man with a remote history of asthma (last used inhaler 5-6 years ago) who is presenting with 1 day chest pain in the setting of recent Pfizer Covid vaccination. He received his second Pfizer vaccine dose 3 days ago. The following day, he experienced low grade fever to 100.4 and mild headache. He felt fine yesterday, but this morning he woke up with dyspnea and feeling like he "couldn''t get air in all the way". He denied feeling chest pressure but endorsed mid sternal chest pain without radiation. The pain was not exacerbated by exercise and was not positional. He presented to an urgent care facility this morning, where they did an EKG that showed ST segment elevations diffusely. He was then transferred to Hospital. he was overall well appearing with slight tachypnea but otherwise normal vital signs. He initially was not endorsing chest pain. They drew a troponin that was elevated to 1515 ng/L with an upper limit of normal 54 (likely 1.5 on our scale). BNP, electrolytes, CBC were all within normal limits. Initial EKG did not have any ST segment elevation. They did a chest XR which did not show any signs of pulmonary edema or cardiomegaly. He later developed chest pain so an EKG was repeated which showed recurrence of the ST elevations diffusely; most prominently in V1-2. Repeat troponin was 2000. He was given a single dose of aspirin 81mg and transferred for further care. In the ED, he was well appearing and no longer endorsing chest pain. He was monitored on continuous telemetry with no abnormalities. His troponin here was 0.27 ng/mL, CRP was elevated to 2.6, he had a mild transaminitis of 41/37 and mildly elevated LDH to 236. Covid antibodies were positive. CBC, ferritin, d-dimer, ESR were all within normal limits, rapid Covid/flu/RSV negative. Repeat EKG was similar to the second EKG with very minimal ST-segment elevations. He denies any URI symptoms, rashes, N/V/D, and joint pain. He''s had good PO intake until today. He is an athlete (currently playing baseball) and has never experienced chest pain with exercise. Surgical hx: T&A Family history: Negative for any cardiac pathology or autoimmune disease Allergies: rash with penicillin Social: here with grandma who is legal guardian Hospital Course: admitted to the cardiology floor for continued monitoring of his troponin levels and EKG. The morning after his admission, his troponin was uptrending slightly to 0.37 and echocardiogram showed mildly depressed systolic function and longitudinal strain, so the decision was made to treat. Cardiac MRI performed prior to treatment showed good systolic function but mild LV late gadolinium enhancement and corresponding hypokinesis. He received one time IVIG 2g/kg and IV methylprednisolone 30mg BID for 2 doses. His chest pain came and went throughout his admission and was treated with ibuprofen and Tylenol as needed. He was transitioned over to PO steroids on 7/20 which he tolerated well. On day of discharge, his troponin levels were trending down. Pt was scheduled for outpatient follow up including ECHO at that time. By time of discharge, patient was well-appearing, vitals stable, demonstrating good PO intake. Chest pain was fully resolved. Prescriptions sent to preferred pharmacy. Follow up with cardiology in place. Discharge instructions and return precautions reviewed with patient and parent, who expressed good understanding and agreement with plan. Reasons for new, changed, and discontinued medications: Prednisone for myocarditis to complete 5 day steroid course (last dose morning of 7/24) Famotidine (GI protection while taking prednisone) Reasons for new, changed, and discontinued equipment: NA Relevant Diagnostic Images/Studies: Echocardiogram 7/19: ? Technically difficult examination due to suboptimal echocardiographic windows. Unable to evaluate the atrial septum, systemic and pulmonary veins, pulmonary arteries, and aortic arch. Coronary artery dilation is not excluded. ? Normal valvular function. ? Normal left ventricular size and low-normal systolic function. Reduced longitudinal strain. ? Qualitatively normal right ventricular systolic function. ? No pericardial effusion. Cardiac MRI 7/19: ? Normal left ventricular size and global systolic function. ? Basal inferoseptal, inferior, and inferolateral left ventricular late gadolinium enhancement with corresponding mild hypokinesis. ? Normal right ventricular size and global systolic function. No right ventricular late gadolinium enhancement or regional wall motion abnormalities. ? No significant valvular dysfunction. ? No coronary artery aneurysms. ? No pericardial effusion. Admission EKG 7/18: ST segment changes, non-specific. Discharge EKG: minimal ST segment changes, improved from admission. Tests Pending Adenovirus PCR QuaNT, Stool Adenovirus PCR QuaNT, Urine CMV Antibody IgG CMV Antibody IgM EBV Antibody IgG EBV Antibody IgM EBV Antibody to EA-D, IgG EBV Antibody to NA, IgG Enterovirus PCR QuaL, Stool HSV I/II Combined Antibody IgG Lyme Antibody, Total Mayo Misc Test Miscellaneous Lab Test Miscellaneous Test Arup Miscellaneous Test Arup Miscellaneous Test Arup Parvovirus B-19 IgG Parvovirus B-19 IgM Parvovirus DNA PCR QuaNT, Blood Respiratory Virus PCR Panel - sendout Viral Culture, Non Respiratory These tests will be followed by the Primary Service at Discharge after Discharge Vitals and Discharge Physical T: 37.1 ?C HR: 64 (Monitored) RR: 20 BP: 120/58 SpO2: 96% HT: 167 cm WT: 94.9 kg BMI: 34 Discharge Physical Exam Gen: Well-appearing, well-developed teenager sitting up in bed. Appropriately interactive./ HEENT: Normocephalic, atraumatic. Moist mucous membranes. EOMI, no conjunctivitis. Resp: Clear to auscultation bilaterally, no increased work of breathing. No wheezes CV: Normal rate, RR with no murmurs, rubs, or gallops. Capillary refill <2 sec. Distal pulses 2+. Abd: Soft, non-distended, non-tender. Normal bowel sounds Ext: Normal range of motion of all extremities, no peripheral edema Skin: Pink, warm, no bruising Neuro: Alert, responsive, developmentally appropriate, normal tone Diagnosis List 1. Chest pain, 07/18/2021 2. Shortness of breath, 07/18/2021 3. Myocarditis, 07/18/2021 Procedure History No Procedure History Social History Smoking Status No Smoking Status Documented Allergies penicillin Laboratory Results Returned 48 Hours Prior to Discharge Labs Last 48 Hours Event Name Event Result Date/Time WBC 7.88 K cells/uL 07/20/21 Hemoglobin 12.6 g/dL 07/20/21 Hematocrit 36.6 % Low 07/20/21 Platelet 298 K cells/uL 07/20/21 MPV 9.1 fL Low 07/20/21 RBC 4.17 M cells/uL Low 07/20/21 MCV 87.8 fL 07/20/21 MCH 30.2 pg 07/20/21 MCHC 34.4 g/dL 07/20/21 Red Cell Distribution Width CV 11.9 % 07/20/21 Nucleated Red Blood Cell % 0 /100 WBC 07/20/21 Nucleated Red Blood Cell Count 0 K cells/uL 07/20/21 Absolute Neutrophil Count 6.38 K cells/uL High 07/20/21 Absolute Lymphocyte Count 0.97 K cells/uL Low 07/20/21 Absolute Eosinophil Count 0.02 K cells/uL Low 07/20/21 Absolute Basophil Count 0.01 K cells/uL Low 07/20/21 Absolute Monocyte Count 0.45 K cells/uL 07/20/21 Absolute Immature Granulocyte Count 0.05 K cells/uL High 07/20/21 Neutrophil/Band 81 % High 07/20/21 Immature Granulocytes 0.6 % High 07/20/21 Lymphocyte 12.3 % Low 07/20/21 Monocyte 5.7 % Low 07/20/21 Eosinophil 0.3 % Low 07/20/21 Basophil 0.1 % Low 07/20/21 Sodium 137 mmol/L 07/19/21 Potassium 5.14 mmol/L High 07/19/21 Chloride 102 mmol/L 07/19/21 CO2 21 mmol/L Low 07/19/21 Anion Gap 14 mmol/L 07/19/21 Glucose Level 133 mg/dL 07/19/21 BUN 11 mg/dL 07/19/21 Creatinine 0.61 mg/dL 07/19/21 Calcium 9.3 mg/dL 07/19/21 Phosphorus 4.5 mg/dL 07/19/21 Magnesium 1.9 mg/dL 07/19/21 Troponin T 0.21 ng/mL Critical 07/21/21 Troponin T 0.22 ng/mL Critical 07/20/21 Troponin T 0.22 ng/mL Critical 07/20/21 C-Reactive Protein 0.77 mg/dL High 07/20/21 Mycoplasma pneumoniae, IgG 1.87 High 07/19/21 Mycoplasma pneumoniae, IgM 0.47 07/19/21 Microbiology Results (Last 30 Days) Micro Results: Updates since 06/21/2021 00:00. Collection date displayed. Cytomegalovirus PCR, blood, QuaNT: (Blood) 07/19/2021. Final Report: No CMV detected by PCR. This test does not detect latent CMV infections. A reference range for this test has not been established. Results should be interpreted in the context of other clinical and laboratory information. This test should not be used to diagnose latent or previous CMV infection. People with latent or previous CMV may not have detectable CMV DNA by this test. The variability of this test should be considered when interpreting results. Changes of approximately three fold in the quantity of CMV DNA detected may be due to variation in the test rather than actual changes in the level of CMV DNA in the sample. Note: This test was developed and its performance characteristics determined by the Hospital. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Epstein-Barr Virus PCR, QuaNT: (Blood) 07/19/2021. Final Report: No EBV detected by PCR. This test does not detect latent EBV infections. A reference range for this test has not been established. Results should be interpreted in the context of other clinical and laboratory information. This test should not be used to diagnose latent or previous EBV infection. People with latent or previous EBV infection may not have detectable EBV DNA by this test. The variability of this test should be considered when interpreting results. Changes of approximately three fold in the quantity of EBV DNA detected may be due to variation in the test rather than actual changes in the level of EBV DNA in the sample. Note: This test was developed and its performance characteristics determined by the Hospital. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Health Care Proxy: Under 18 years old MOLST: Under 18 years old Follow-Up and Patient Instructions Patient Instructions He was admitted for management of myocarditis thought to be due to his SARS-CoV2 vaccination. Myocarditis is inflammation of the heart muscle that can happen with many different types of infections and virusesHe received IVIG and steroids. He had multiple EKGs, echocardiograms, and a cardiac MRI which showed mild changes but overall good heart function. His chest pain and heart studies improved throughout his stay and he was safe for discharge home. He should refrain from strenuous exercise for the next couple of months and you should discuss when it is safe to return to exercise with your outpatient cardiologist. Medications: --- Prednisone 30mg twice per day for _ days (last day _) --- Famotidine 20mg twice per day for _ days (last day _) It is important to minimize activity that raises his heart rate for the next 3 months. This will be discussed in more detail at cardiology appointment. Until then, no strenuous exercise. Attending Attestation CARDIOLOGY INPATIENT ATTENDING DISCHARGE NOTE: I reviewed the history and hospital course, examined the patient on rounds, reviewed the testing, discussed the findings with the Cardiology Team, and participated directly in formulation of the assessment and plan for discharge. I have reviewed and agree with the documentation above with the following additions/revisions:17yo admitted with COVID vaccine associated myocarditis, with repolarization abnormalities on ECG, elevated troponin, and chest pain within days after receiving his 2nd dose. He remained hemodynamically stable with preserved ventricular systolic function. Echo did show abnormal strain, and MRI showed LGE with focal hypokinesis. Due to increasing troponin level, he was treated with IVIG and steroids with improvement in troponins. No significant arrhythmia. Plan for follow-up next week with MISC/vaccine myocarditis group, and to complete a 5-day course of steroids. Restricted from sports and intense activity for likely at least 3 months.


VAERS ID: 1498157 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-07-19
Onset:2021-07-20
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-07-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Cardiac telemetry, Chest pain, Echocardiogram normal, Ejection fraction normal, Electrocardiogram abnormal, Myocarditis, Pericarditis, Troponin increased
SMQs:, Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: 16 year old previously healthy male presented with chest pain consistent with cardiac chest pain that developed 24 hours after the initial vaccination. On presentation, EKG with findings consistent with myocarditis vs pericarditis. Troponin peak was approximately 5.2 on 7/22 and subsequently downtrended. Echocardiogram obtained which showed normal EF, no pericardial effusion, and no wall motion abnormalities. He was observed on cardiac telemetry with serial EKGs and troponins and was cleared for discharge by cardiology and infectious disease. Symptoms were treated conservatively--NSAIDs PRN. He is currently in the recovery phase from the myocarditis and will follow outpatient with cardiology.


VAERS ID: 1500756 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-07-17
Onset:2021-07-20
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-07-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram normal, Immunoglobulin therapy, Pyrexia, Troponin increased
SMQs:, Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: peanut, soy and tree nut
Diagnostic Lab Data: Patient had elevated troponin on admission to the hospital which increased over the subsequent 24 hours after hospitalization. EKG and echo were normal. Due to continuation in rise of troponin he received IVIG and IV steroids.
CDC Split Type:

Write-up: Patient had fever the day after the of receipt of the vaccine (on 7/18) but then on 7/20 started to complain of mid sternal chest pain which lasted that day. He was evaluated in the ER and based on labs and history, admitted for evaluation. His chest pain had resolved by the following day.


VAERS ID: 1500847 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-07-16
Onset:2021-07-21
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-07-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / IM

Administered by: Military       Purchased by: ?
Symptoms: Chest pain, Dyspnoea, Echocardiogram, Left ventricular dysfunction, Magnetic resonance imaging heart, Myocarditis
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Cardiac MRI 7/22 Cardiac echo 7/23
CDC Split Type:

Write-up: Myocarditis. Patient presented with chest pain and SOB 5-6 days after receiving vaccine #1. Found to have myocarditis with depressed LV function


VAERS ID: 1500874 (history)  
Form: Version 2.0  
Age: 12.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-07-07
Onset:2021-07-20
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-07-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Public       Purchased by: ?
Symptoms: CSF glucose decreased, CSF lymphocyte count normal, CSF neutrophil count increased, CSF protein increased, CSF red blood cell count positive, CSF white blood cell count increased, Cerebrovascular disorder, Chest X-ray normal, Computerised tomogram abdomen abnormal, Computerised tomogram head abnormal, Computerised tomogram pelvis abnormal, Computerised tomogram thorax abnormal, Condition aggravated, Demyelination, Disorientation, Disseminated tuberculosis, Fatigue, Headache, Infection, Interferon gamma release assay positive, Ischaemia, Latent tuberculosis, Lung opacity, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Mental status changes, Nervous system disorder, Nodule, Pulmonary mass, Pyrexia, SARS-CoV-2 antibody test negative, Screaming, Spinal cord disorder, Splenomegaly, Tuberculosis
SMQs:, Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Retroperitoneal fibrosis (broad), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Optic nerve disorders (broad), Cardiomyopathy (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Dehydration (broad), Sepsis (broad), Opportunistic infections (narrow), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: One month of mild cough, fatigue, weight loss.
Preexisting Conditions:
Allergies: None
Diagnostic Lab Data: Head CT scan 7/21/21: Scattered hypodense regions throughout both cerebral hemispheres but most pronounced in the left frontal lobe, nonspecific though diagnostic considerations including ischemia and/or demyelination. Further evaluation with MRI recommended. Brain and spine MRI 7/21/21: Innumerable nodular enhancing lesions throughout bilateral cerebral and cerebellar hemispheres with overlying leptomeningeal enhancement, along with two enhancing nodules within the pons as described. Overall appearance is most concerning for infection, with differential including atypical causes such as tuberculosis or parasitic (such as neurocysticercosis or amoebic). Metastatic disease or neurosarcoidosis could also have this appearance but are felt to be less likely. Two small nodular enhancing foci within the lower thoracic spinal cord as described. CT chest/abd/pelvis 7/21/21: 1. Innumerable tiny nodules diffusely throughout both lungs, with also patchy opacities in the left upper lobe and lingula, and in the dependent lung bases. Findings are suspicious for infection, including atypical etiologies such as tuberculosis. 2. Wedge-shaped area of hypoenhancement within the left kidney, and a smaller area in the left upper pole. Findings may represent infection or less likely infarction. 3. Mild splenomegaly. COVID antibody 7/21/21: negative CSF 7/21/21: WBC 31 (Lymph 60%, PMN 29%), RBC 7, gluc 32, prot 113
CDC Split Type:

Write-up: Prior to vaccine with a few weeks of weight loss, fatigue, and mild cough. Two days after vaccination with headache, self resolved. Then around 7/17 she developed tactile fevers, increasing fatigue, and headache. On 7/20 PM she had acute onset of altered mental status- she was screaming and disoriented. She was taken to the Hospital emergency department on 7/21 AM. Work up initially concerning for ADEM, although subsequent imaging consistent with miliary TB with CNS disease (tuberculomas). Patient was exposed to grandmother with MDR pulmonary TB in 2018. Patient was prescribed treatment for LTBI (QuantGold pos but negative CXR) but unclear if she took it. Currently started on therapy for MDR TB and remains hospitalized.


VAERS ID: 1502022 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-07-21
Onset:2021-07-23
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-07-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0181 / 2 - / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Myocarditis, Troponin
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Aripiprazole, Vyvanse, Clonidine, Lamotrigine
Current Illness:
Preexisting Conditions: ADHD, Bipolar
Allergies:
Diagnostic Lab Data: Troponin 2.96 (7/26), 2.71 (7/25)
CDC Split Type:

Write-up: Myocarditis- on ibuprofen, 2 days post admission


VAERS ID: 1502431 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-07-23
Onset:2021-07-25
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-07-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Electrocardiogram abnormal, Intensive care, Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: migraines
Allergies: None
Diagnostic Lab Data: Troponin 7/26 AM - 18
CDC Split Type:

Write-up: Approximately 24 hours after receiving his Covid he developed chest pain. This initially was intermittent and then became persistent and severe approximately 48 hours after receiving his vaccine. In the emergency department labs were drawn that showed an elevated troponin to 18 and EKG consistent with myocarditis. He was then admitted to the intermediate care unit


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=6&VAX=COVID19&VAXMAN=PFIZER/BIONTECH&HOSPITAL=Yes&DIED=No&WhichAge=range&LOWAGE=(0)&HIGHAGE=(19)&VAX_YEAR_LOW=2021&VAX_MONTH_LOW=07&VAX_YEAR_HIGH=2021&VAX_MONTH_HIGH=07


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166